MK-5172 structure
|
Common Name | MK-5172 | ||
---|---|---|---|---|
CAS Number | 1206524-85-7 | Molecular Weight | 554.635 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 825.0±65.0 °C at 760 mmHg | |
Molecular Formula | C29H38N4O7 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 452.7±34.3 °C |
Use of MK-5172MK-5172 is a novel P2-P4 quinoxaline macrocyclic HCV NS3/4a protease inhibitor currently in clinical development. |
Name | (1aR,5S,8S,10R,22aR)-5-tert-butyl-14-methoxy-3,6-dioxo-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid |
---|---|
Synonym | More Synonyms |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 825.0±65.0 °C at 760 mmHg |
Molecular Formula | C29H38N4O7 |
Molecular Weight | 554.635 |
Flash Point | 452.7±34.3 °C |
Exact Mass | 554.274048 |
PSA | 143.67000 |
LogP | 4.64 |
Vapour Pressure | 0.0±3.1 mmHg at 25°C |
Index of Refraction | 1.616 |
S1492_Selleck |
(1R,18R,20R,24S,27S)-7-Methoxy-24-(2-methyl-2-propanyl)-22,25-dioxo-2,21-dioxa-4,11,23,26-tetraazapentacyclo[24.2.1.0.0.0]nonacosa-3,5,7,9,11-pentaene-27-carboxylic acid |
8H-7,10-Methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid, 5-(1,1-dimethylethyl)-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-, (1aS,5S,8S,10R,22aR)- |
8H-7,10-Methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid, 5-(1,1-dimethylethyl)-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-, (1aR,5S,8S,10R,22aR)- |
(1R,18R,20S,24S,27S)-7-Methoxy-24-(2-methyl-2-propanyl)-22,25-dioxo-2,21-dioxa-4,11,23,26-tetraazapentacyclo[24.2.1.0.0.0]nonacosa-3,5(10),6,8,11-pentaene-27-carboxylic acid |
UNII-RU4QU6O6X6 |
MK-5172 |
Grazoprevir |